BioMerieux Total Current Liabilities 2017-2023 | BMXMF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

BioMerieux total current liabilities for 2023 were $1.177B, a 1.25% decline from 2022.
BioMerieux total current liabilities for 2022 were $1.192B, a 5.39% increase from 2021.
BioMerieux total current liabilities for 2021 were $1.131B, a 7.16% increase from 2020.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

BioMerieux total current liabilities for 2023 were $1.177B, a 1.25% decline from 2022.
BioMerieux total current liabilities for 2022 were $1.192B, a 5.39% increase from 2021.
BioMerieux total current liabilities for 2021 were $1.131B, a 7.16% increase from 2020.

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$114.1B
Cencora (COR)	$43.3B
DiDi Global (DIDIY)	$24.3B
ICON (ICLR)	$24.2B
Avantor (AVTR)	$17.2B
Natera (NTRA)	$16.1B
Revvity (RVTY)	$15.3B
Viatris (VTRS)	$13.8B
CochLear (CHEOY)	$13.1B
Solventum (SOLV)	$11.7B
Medpace Holdings (MEDP)	$10.6B
Charles River Laboratories (CRL)	$9.8B
Sonic Healthcare (SKHHY)	$8.9B
Doximity (DOCS)	$8.1B
HealthEquity (HQY)	$7.3B
Bausch + Lomb (BLCO)	$6.7B
PACS (PACS)	$5.9B
Life Times (LTH)	$5B
Organon (OGN)	$4.7B
Sotera Health (SHC)	$4.5B
Surgery Partners (SGRY)	$4B
GoodRx Holdings (GDRX)	$2.7B
Concentras Parent (CON)	$2.7B
Ardent Health Partners (ARDT)	$2.6B
BrightSpring Health Services (BTSG)	$2.5B
Alignment Healthcare (ALHC)	$2.1B
Ryman Healthcare (RYHTY)	$2B
Premier (PINC)	$1.9B
CareDx (CDNA)	$1.6B
Teladoc Health (TDOC)	$1.5B